Oral Feeding Outcome after Analgesic and Sedative Exposure in VLBW Preterm Infant
14 September 2017
01 May 2018
08 June 2018 (online)
Objective The objective of this study was to assess the association of analgesics and sedatives on oral feeding function and need for feeding tube at discharge in the very low birth weight (VLBW) (<1,500 g) preterm infant.
Study Design A retrospective review of surviving inborn infants < 1,500 g and < 32 weeks' gestation (n = 209), discharged between January 1, 2012, and December 31, 2014, from the neonatal intensive care unit identified exposure to analgesic and sedative medications, demographics, medical course, and nasogastric or gastrostomy tube (GT) feeding at discharge. Predictive modeling with logistic regression to identify independent factors associated with discharge on tube feedings.
Results Out of 209, 45 (21.5%) infants received an analgesic/sedative with 23 out of 45 (51.1%) discharged with tube feedings. Infants discharged with tube feedings were born smaller, of younger gestation, with greater SNAPPE-II scores, periventricular leukomalacia, chronic lung disease, postnatal glucocorticoids, lansoprazole, and longer time intubated. After adjusting for covariates, exposure to analgesic/sedatives (fentanyl, midazolam, or morphine) was independently predictive of discharge on tube feedings.
Conclusion Analgesic and sedative exposure in VLBW infants is highly associated with poor oral feeding and need for tube feedings at discharge.
- 1 Roofthooft DW, Simons SH, Anand KJ, Tibboel D, van Dijk M. Eight years later, are we still hurting newborn infants?. Neonatology 2014; 105 (03) 218-226
- 2 Johnston C, Barrington KJ, Taddio A, Carbajal R, Filion F. Pain in Canadian NICUs: have we improved over the past 12 years?. Clin J Pain 2011; 27 (03) 225-232
- 3 Batton DG, Barrington KJ, Wallman C. ; American Academy of Pediatrics Committee on Fetus and Newborn; American Academy of Pediatrics Section on Surgery; Canadian Paediatric Society Fetus and Newborn Committee. Prevention and management of pain in the neonate: an update. Pediatrics 2006; 118 (05) 2231-2241
- 4 Anand KJ, Hall RW, Desai N. , et al; NEOPAIN Trial Investigators Group. Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet 2004; 363 (9422): 1673-1682
- 5 Bhandari V, Bergqvist LL, Kronsberg SS, Barton BA, Anand KJ. ; NEOPAIN Trial Investigators Group. Morphine administration and short-term pulmonary outcomes among ventilated preterm infants. Pediatrics 2005; 116 (02) 352-359
- 6 Menon G, Boyle EM, Bergqvist LL, McIntosh N, Barton BA, Anand KJ. Morphine analgesia and gastrointestinal morbidity in preterm infants: secondary results from the NEOPAIN trial. Arch Dis Child Fetal Neonatal Ed 2008; 93 (05) F362-F367
- 7 Ing C, DiMaggio C, Whitehouse A. , et al. Long-term differences in language and cognitive function after childhood exposure to anesthesia. Pediatrics 2012; 130 (03) e476-e485
- 8 Durrmeyer X, Vutskits L, Anand KJ, Rimensberger PC. Use of analgesic and sedative drugs in the NICU: integrating clinical trials and laboratory data. Pediatr Res 2010; 67 (02) 117-127
- 9 Ferguson SA, Ward WL, Paule MG, Hall RW, Anand KJ. A pilot study of preemptive morphine analgesia in preterm neonates: effects on head circumference, social behavior, and response latencies in early childhood. Neurotoxicol Teratol 2012; 34 (01) 47-55
- 10 Duerden EG, Guo T, Dodbiba L. , et al. Midazolam dose correlates with abnormal hippocampal growth and neurodevelopmental outcome in preterm infants. Ann Neurol 2016; 79 (04) 548-559
- 11 McPherson C, Haslam M, Pineda R, Rogers C, Neil JJ, Inder TE. Brain injury and development in preterm infants exposed to fentanyl. Ann Pharmacother 2015; 49 (12) 1291-1297
- 12 FDA. FDA Drug Safety Communication: FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women; 2016
- 13 Goldstein AM, Hofstra RM, Burns AJ. Building a brain in the gut: development of the enteric nervous system. Clin Genet 2013; 83 (04) 307-316
- 14 Staiano A, Boccia G, Salvia G, Zappulli D, Clouse RE. Development of esophageal peristalsis in preterm and term neonates. Gastroenterology 2007; 132 (05) 1718-1725
- 15 Tutuian R. ; Clinical Lead Outpatient Services and Gastrointestinal Function Laboratory. Adverse effects of drugs on the esophagus. Best Pract Res Clin Gastroenterol 2010; 24 (02) 91-97
- 16 Reveille RM, Goff JS, Hollstrom-Tarwater K. The effect of intravenous diazepam on esophageal motility in normal subjects. Dig Dis Sci 1991; 36 (08) 1046-1049
- 17 Rommel N, van Wijk M, Boets B. , et al. Development of pharyngo-esophageal physiology during swallowing in the preterm infant. Neurogastroenterol Motil 2011; 23 (10) e401-e408
- 18 Lee JH, Chang YS, Yoo HS. , et al. Swallowing dysfunction in very low birth weight infants with oral feeding desaturation. World J Pediatr 2011; 7 (04) 337-343
- 19 Jadcherla SR. Pathophysiology of aerodigestive pulmonary disorders in the neonate. Clin Perinatol 2012; 39 (03) 639-654
- 20 Hall RW, Anand KJ. Pain management in newborns. Clin Perinatol 2014; 41 (04) 895-924
- 21 Anand KJ. Pediatric critical care: grand challenges for a glowing future. Front Pediatr 2014; 2: 35
- 22 Kraichely RE, Arora AS, Murray JA. Opiate-induced oesophageal dysmotility. Aliment Pharmacol Ther 2010; 31 (05) 601-606
- 23 Chang YP. Evidence for adverse effect of perinatal glucocorticoid use on the developing brain. Korean J Pediatr 2014; 57 (03) 101-109
- 24 Kersbergen KJ, de Vries LS, van Kooij BJ. , et al. Hydrocortisone treatment for bronchopulmonary dysplasia and brain volumes in preterm infants. J Pediatr 2013; 163 (03) 666-671